Companies / Israel
AstraZeneca Sues Teva
March 2006 | Legal NewsAnglo-Swedish drugmaker AstraZeneca has filed a lawsuit against Israeli generics major Teva over an alleged infringement of its blockbuster ulcer treatment Nexium. AstraZeneca claims the lawsuit is a response to an application filed by US drug firm Ivax to produce generic versions of Nexium. Teva acquired Ivax in 2005 for US$7.4bn. Nexium is AstraZeneca's best selling medicine, generating sales of US$4.6bn last year.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
